Navigation Links
RSCI Announces Two Additions to Its Science Advisory Board, Calling for More Stem Cell Research on Diabetes

WASHINGTON, Oct. 20 /PRNewswire/ -- The Repair Stem Cell Institute (RSCI) today announced two additions to its world-leading Science Advisory Board (SAB), extending its stem cell research proficiency in the process. Don Margolis, RSCI chairman, noted that "Our first five appointees had two things in common: pioneering stem cell research and successfully helping patients with a variety of illnesses considered incurable. Today we add two Massachusetts researchers, David Matzilevich, M.D., Ph.D. and Mariano Ubeda, M.D., Ph.D. thus stretching our expertise to fields not being covered by others. They fit well with our innovative five."

According to Margolis, the two new additions cover still more ground. "Dr. Matzilevich's focus is on adult stem cell and cord blood uses as well as molecular-based approaches to Schizophrenia and Bipolar Disorder, and he is contributing greatly to these fields. Dr. Ubeda has made significant scientific contributions to the field of chronic degenerative diseases, and is working on advanced stem cell therapies to try to combat the greatest pandemic in world medical history--Diabetes--a disease for which current stem cell research doesn't begin to match the need. We at RSCI are committed to improving the lives of diabetic patients.

"Our SAB Chairman, Kit Arom, M.D., Ph.D. of Minneapolis and Bangkok, is the first doctor in the world to personally inject stem cells into the heart muscles of over 100 late-stage heart patients, accepting patients with no other options by standard cardiology and improving their lives at a 70% success rate. Now he wants to get involved in the fight against the diabetes pandemic.

"Deputy Chairman Roberto Fernandez Vina, M.D. of Argentina is a world-pioneer, having completed successful clinical trials on heart patients in South America before the first such trial even started in the USA. He is also the author of the first stem cell clinical trial for type 2 Diabetes.

"Zannos Grekos, M.D. is the only cardiologist in the world to offer critically-ill American heart patients a full program of stem cell therapy including about two years of pre and post treatment care. Now he wants to help in the battle against diabetes, and we are delighted to have his support."

Carlos Lima, M.D. adds still another specialty to RSCI's SAB. He is the world's pioneer stem cell physician for spinal cord injured paraplegics. "Dr. Lima has some of them actually walking with braces and walkers, after years of special rehabilitation," says Margolis, "It's not an easy battle, but Dr. Lima is leading the way.

"Rounding out our panel is Shimon Slavin, M.D. of Israel. He was the first in the world to go beyond bone marrow transplants and help cancer patients with cellular therapy. He was also first to cure a bubble baby with cellular therapy--a task other stem cell researchers are still struggling with."


The Repair Stem Cell Institute LLC (RSCI) is a global public service firm dedicated to educating the public about repair stem cells/adult stem cell research and treatments worldwide. RSCI was founded in April 2008 with offices in Washington, D.C., Dallas, Texas and Bangkok, Thailand.

SOURCE The Repair Stem Cell Institute LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. ADVENTRX Announces Restructuring and Cost Reduction Initiatives
2. Resverlogix Announces Closing of Debt Redemption
3. Pittsburgh Technology Council Announces Technology 50
4. China Bio Energy Holdings Group Announces Financing and Exercise of Warrants
5. Pioneer(R) Surgical Technology Announces First Human Implants of New nanOss(TM)-Cervical Fusion Device
6. CryoLife Announces Release Date and Teleconference Call Details for Third Quarter 2008 Financial Results
7. Exiqon A/S Announces U.S. Subsidiary Name Change From Oncotech, Inc. to Exiqon Diagnostics, Inc.
8. Vasogen Announces Third Quarter 2008 Results
9. Volcano Corporation Announces Launch of PrimeWire(TM) Pressure Guidewire and s5-FFR Option for Existing Fleet of s5 IVUS Consoles
10. SourceSolution Announces the Launch of Its Initiative to Simplify Outsourcing Decisions for Biotechnology and Pharmaceutical Companies
11. Ground Zero Pharmaceuticals Announces Expansion of Regulatory and Product Development Consulting Services
Post Your Comments:
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. , ... tests introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
Breaking Biology Technology:
(Date:6/2/2016)... -- The Department of Transport Management (DOTM) of ... US Dollar project, for the , Supply and ... and IT Infrastructure , to Decatur ... of Identity Management Solutions. Numerous renowned international vendors participated in ... was selected for the most compliant and innovative solution. ...
(Date:6/2/2016)... June 2, 2016 Perimeter Surveillance ... Unmanned Systems, Physical Infrastructure, Support & Other Service  ... visiongain offers comprehensive analysis of the global ... will generate revenues of $17.98 billion in 2016. ... Inc, a leader in software and hardware technologies for ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing ...  3D medical LCD display is the latest premium product recently added to the range ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):